© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
May 25, 2021
Ferring Pharmaceuticals and Rebiotix reported results from a trial on their therapy, RBX2660, which shows promise as a Clostridioides difficile infection (CDI) treatment.
May 15, 2021
A discussion with William Schaffner surrounding the CDC recently updating their recommendations on mask wearing.
April 28, 2021
The proportion of cases with CDI in perforated appendicitis was found to be greater in comparison to the non-perforated cases.
April 24, 2021
CDI prevalence among those hospitalized with a COVID-19 infection was not found to be increased despite more use of antibiotics.